InvestorsHub Logo
Followers 2543
Posts 250754
Boards Moderated 35
Alias Born 05/06/2014

Re: frosr6 post# 45598

Monday, 01/11/2016 6:01:51 PM

Monday, January 11, 2016 6:01:51 PM

Post# of 144814
$PMCB Mature markets will push major pharmaceutical companies to seek more deals. Hopefully $PMCB will be on the list as well.

The world's pharmaceutical giants struggle to generate additional revenue at the rate investors expect, and are projected to lose $17 billion from expired patents in 2016, according to PricewaterhouseCoopers. As a result, executives are eager to acquire fast-growing businesses to show growth. In 2015, pharmaceutical and biotech companies set a new record for the value of the deals they struck in a single year at $462.2 billion. The sheer volume of deals also grew by 21.5 percent, up to 768 deals, from 632 in 2014, according to EY.

http://www.ibtimes.com/top-pharma-biotech-trends-what-watch-out-2016-2235052?rel=rel1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News